*  
2000

Salgado R, Benoy I, Weytjens R, Vermeulen PB, Dirix LY. Serum vascular endothelial growth factor load and interleukin-6 in cancer patients - reply. Br J Cancer. 2000 Jun;82(11):1896.

Vermeulen P, Hoekx L, Colpaert C, Wyndaele JJ, Van Marck E. Biphasic sarcomatoid carcinoma (carcinosarcoma) of the renal pelvis with heterologous chondrogenic differentiation.Virchows Arch. 2000 Aug;437(2):194-7.

1999

Kumar-Singh S, Weyler J, Martin MJ, Vermeulen PB, Van Marck E. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression. J Pathol. 1999 Sep;189(1):72-8.

Lauwers P, Hubens G, Hendriks J, Vermeulen P, Schuerwegh A, Stevens WJ, De Clerck LS, Dirix L, Van Marck E, Hubens A, Eyskens E. Effects of suramin on anastomotic colon tumors in a rat model. Eur Surg Res. 1999;31(4):347-56.

Dirix LY, Van Oosterom AT. Soft tissue sarcoma in adults. Curr Opin Oncol. 1999 Jul;11(4):285-95. Review.

Salgado R, Vermeulen PB, Benoy I, Weytjens R, Huget P, Van Marck E, Dirix LY. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br J Cancer. 1999 May;80(5-6):892-7.

Gasparini G, Toi M, Miceli R, Vermeulen PB, Dittadi R, Biganzoli E, Morabito A, Fanelli M, Gatti C, Suzuki H, Tominaga T, Dirix LY, Gion M. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. Cancer J Sci Am. 1999 Mar-Apr;5(2):101-11.

Vermeulen PB, Salven P, Benoy I, Gasparini G, Dirix LY. Blood platelets and serum VEGF in cancer patients. Br J Cancer. 1999 Jan;79(2):370-3.

Vermeulen PB, Van den Eynden GG, Huget P, Goovaerts G, Weyler J, Lardon F, Van Marck E, Hubens G, Dirix LY. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer. Br J Cancer. 1999 Jan;79(2):316-22.

1998

Benoy I, Vermeulen P, Wuyts H, Dirix L.Vascular endothelial cell growth factor (VEGF) serum concentrations change according to the phase of the menstrual cycle. Eur J Cancer. 1998 Jul;34(8):1298-9.

Tjalma W, Van Marck E, Weyler J, Dirix L, Van Daele A, Goovaerts G, Albertyn G, van Dam P. Quantification and prognostic relevance of angiogenic parameters in invasive cervical cancer. Br J Cancer. 1998 Jul;78(2):170-4.

Gasparini G, Brooks PC, Biganzoli E, Vermeulen PB, Bonoldi E, Dirix LY, Ranieri G, Miceli R, Cheresh DA. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin Cancer Res. 1998 Nov;4(11):2625-34.

1997

Dirix LY, Libura M, Libura J, Vermeulen PB, De Bruijn EA, Van Oosterom AT. In vitro toxicity studies with mitomycins and bleomycin on endothelial cells. Anticancer Drugs. 1997 Oct;8(9):859-68.

Vermeulen PB, Dirix LY, Martin M, Lemmens J, Van Oosterom AT. Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b. J Natl Cancer Inst. 1997 Sep 3;89(17):1316-7.

Dirix LY, Vermeulen P, De Wever I, Van Oosterom AT. Soft tissue sarcoma in adults. Curr Opin Oncol. 1997 Jul;9(4):348-59. Review.

Vermeulen PB, Dirix LY, Libura J, Vanhoolst IF, Van Marck E, Van Oosterom AT. Correlation of the fractions of proliferating tumor and endothelial cells in breast and colorectal adenocarcinoma is independent of tumor histiotype and microvessel density. Microvasc Res. 1997 Jul;54(1):88-92.

Kumar-Singh S, Vermeulen PB, Weyler J, Segers K, Weyn B, Van Daele A, Dirix LY, Van Oosterom AT, Van Marck E. Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma. J Pathol. 1997 Jun;182(2):211-6.

Dirix LY, Vermeulen PB, Pawinski A, Prove A, Benoy I, De Pooter C, Martin M, Van Oosterom AT. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer. 1997;76(2):238-43.

Vermeulen PB, Libura M, Libura J, O'Neill PJ, van Dam P, Van Marck E, Van Oosterom AT, Dirix LY. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Res Treat. 1997 Jan;42(2):165-72.

1996

Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996 Dec;32A(14):2474-84. Review.

Vermeulen PB, Dirix LY, Van Marck E, Van Oosterom AT. High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis Group. Br J Cancer. 1996 Nov;74(9):1506-7.

Dirix LY, Vermeulen PB, Hubens G, Benoy I, Martin M, De Pooter C, Van Oosterom AT. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol. 1996 Oct;7(8):843-8.

Dirix LY, Vermeulen PB, Van Oosterom AT, Gasparini G. Microvascular count and prognosis in colorectal cancer. J Clin Oncol. 1996 Aug;14(8):2400-3.

Hubens G, Pauwels M, Hubens A, Vermeulen P, Van Marck E, Eyskens E. The influence of a pneumoperitoneum on the peritoneal implantation of free intraperitoneal colon cancer cells. Surg Endosc. 1996 Aug;10(8):809-12.

Vermeulen PB, Roland L, Mertens V, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY. Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvasc Res. 1996 Mar;51(2):164-74.

Dirix LY, Vermeulen PB, Fierens H, De Schepper B, Corthouts B, Van Oosterom AT. Long-term results of continuous treatment with recombinant interferon-alpha in patients with metastatic carcinoid tumors--an antiangiogenic effect? Anticancer Drugs. 1996 Feb;7(2):175-81.

1995

Vermeulen PB, Libura J, Libura M, Hellemans PW, Van Marck E, Van Oosterom AT, Dirix LY. Re: Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J Natl Cancer Inst. 1995 Dec 6;87(23):1797-8; author reply 1801-2.

Vermeulen PB, Dirix LY, Pelgrims G, Van Oosterom AT. 5-fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Cancer. 1995 Aug 1;76(3):528-30.

Vermeulen PB, Verhoeven D, Fierens H, Hubens G, Goovaerts G, Van Marck E, De Bruijn EA, Van Oosterom AT, Dirix LY. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer. 1995 Feb;71(2):340-3.

Vermeulen PB, Verhoeven D, Hubens G, Van Marck E, Goovaerts G, Huyghe M, De Bruijn EA, Van Oosterom AT, Dirix LY. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann Oncol. 1995 Jan;6(1):59-64.
Our articles...